AC
PHAT icon

Allstate Corporation’s Phathom Pharmaceuticals PHAT Stock Holding History

Allstate Corporation’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
32,875
+188
+0.6% +$2.15K ﹤0.01% 1154
2026
Q1 		$363K Buy
+32,687
New +$413K ﹤0.01% 1054

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Allstate Corporation's PHAT Position: Q2 2026 in Review

Allstate Corporation increased its Phathom Pharmaceuticals (PHAT) stake by 0.58% in Q2 2026, buying an estimated $2.15K and bringing the position to 32,875 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #1154.

Allstate Corporation first reported a position in PHAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $363K in Q1 2026. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Allstate Corporation held 32,875 shares of Phathom Pharmaceuticals worth $357K as of Q2 2026.
  • Allstate Corporation bought 188 Phathom Pharmaceuticals shares in Q2 2026, an estimated $2.15K.
  • Phathom Pharmaceuticals made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1154 holding.
  • Allstate Corporation first reported a position in Phathom Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Allstate Corporation's Phathom Pharmaceuticals position peaked at $363K in Q1 2026.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.